{"identifier":"nobleid:/w1/20260525/F443BDE5","arkIdentifier":"ark:/48914/w1/20260525/F443BDE5","version":1,"workTitle":"NAPOLI-3: A randomized, open-label phase 3 study of liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naïve patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).","workType":"Journal Article","authors":"Zev A. Wainberg, Davide Melisi, Teresa Macarulla, Roberto Pazo-Cid, Sreenivasa R Chandana, Christelle de la Fouchardière, Andrew Dean, Igor Kišš, Woo‐Jin Lee, Thorsten Oliver Goetze","description":null,"workUrl":null,"createdAt":"2026-05-25T08:40:40.785022Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260525/F443BDE5.v1"}